Technology News and Research

RSS

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Theraclone Sciences, Inc., a Seattle-based biotechnology company, and Zenyaku Kogyo Co., Ltd., a pharmaceutical company based in Tokyo, today announced that they have entered into a multi-year research and development agreement.

5 Oct 2009

Lupin grants Salix exclusive rights to its bioadhesive drug delivery technology for use with rifaximin

Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin’s proprietary technology.

5 Oct 2009

Oral Cancer Foundation initiates program to donate VELscope screening systems

The Oral Cancer Foundation recently initiated a program of donating VELscope® Oral Cancer Screening Systems to free clinics and others located in, and helping communities with, underserved populations.

5 Oct 2009

New distributor program from A-Life Medical

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today that A-Life Hospital, its wholly owned subsidiary, introduced a new distributor program, A-Life Partners.

5 Oct 2009

Former President Clinton awards certification for new clean water system

The first chlorination system designed for cities in poor countries is now operating in Port-au-Prince, Haiti, announced Andrew Weiss at the Clinton Global Initiative (CGI) meeting in New York last week. "It's a great success," said Weiss.

5 Oct 2009

NHIT achieves milestone with NHIN CONNECTfx gateway software

Nationwide Health Information Technology, Inc. (NHIT) today announced the milestone of 4,000 production transactions processed through the NHIN using CONNECTfx based on the U.S. Government's open-source CONNECT solution.

5 Oct 2009

Intensive care units not designed for end-of-life care

Almost half of the patients who die in intensive care units die within 24 hours, but the environment is not equipped to provide good end-of-life care. Most relatives are nevertheless happy with the care given, shows a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

5 Oct 2009

Registry to help patients in need of bone marrow transplants

Nearly 70 percent of patients needing a marrow transplant do not have a matching donor in their family, leaving minorities particularly vulnerable to finding a donor who can provide a perfect match of common tissue types, according to Be the Match®, a movement that engages the public to help patients in need of bone marrow or umbilical cord blood transplants.

5 Oct 2009

Hansen Medical to exhibit its Lynx Robotic Ablation Catheter at the workshop on Cardiac Arrhythmias

Hansen Medical, Inc. will showcase its new Lynx Robotic Ablation Catheter for the first time at Venice Arrhythmias 2009, the 11th International Workshop on Cardiac Arrhythmias, Oct. 4-7, in Venice, Italy. The Lynx catheter is a small, flexible irrigated ablation catheter for customers in Europe to offer stability during the treatment of Atrial Fibrillation (AF).

5 Oct 2009

Myocardial and neurological effects of Tβ4 presented

REGENERX BIOPHARMACEUTICALS, INC. today reported on the results of several important research programs with Thymosin beta 4 (Tβ4) presented at the Second International Symposium on Thymosins in Health and Disease, in Catania, Italy.

5 Oct 2009

DAS Family Holdings invests in Medical Technologies Unlimited

David Schwedel confirmed that DAS Family Holdings, LP has invested approximately $4 million in Medical Technologies Unlimited, Inc., a developer of advanced medical devices.

5 Oct 2009

Successful auction sale of five drug program intellectual properties

Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that there was a successful auction sale of five drug program intellectual properties on September 30, 2009.

5 Oct 2009

GeckoSystems happy about Forbes.com's recent press coverage

GeckoSystems Intl. Corp. announced today that they are very pleased with the recent press coverage they have received from Forbes.com and other notable online authors.

5 Oct 2009

Researchers engineer antidotes for blood-thinner aptamers

Imagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately - because the blood thinner and antidote were designed to work together. Researchers at Duke University Medical Center have engineered a way to do this for an entire, versatile class of drugs called aptamers and published their findings in Nature Medicine.

4 Oct 2009

Scripps Health expands its spend management agreement with MedAssets

MedAssets, Inc. today announced that it has renewed and expanded its spend management agreement with Scripps Health, an award-winning integrated healthcare delivery network based in San Diego, California. MedAssets will continue to provide its spend management solutions including group purchasing services, supply chain data and analytics tools and physician preference item consulting services for implantable medical devices.

3 Oct 2009

Xcellerex and Itero collaborate in production of an undisclosed therapeutic protein

Xcellerex, Inc. and Itero Biopharmaceuticals, Inc. announced today that they have signed a Letter of Intent to enter into a strategic collaboration for the production of Itero’s lead product, an undisclosed commercially differentiated therapeutic protein. Itero will initiate technology transfer for the product to Xcellerex immediately.

3 Oct 2009

GeneMedRx software warns patients and physicians if tamoxifen benefit is at risk

One hundred eighty thousand women will be diagnosed with breast cancer this year. Eighty thousand will start taking the drug tamoxifen to prevent the recurrence of their ER (estrogen receptor) positive breast cancers. The treatment is successful in two-thirds of the women who take it. Genelex Corporation (Seattle) is now offering Tamoxitest(TM) that could improve this success rate to greater than 90% by addressing both of the common causes of tamoxifen treatment failure.

3 Oct 2009

Electronic medical records: A valuable asset to healthcare industry

Hundreds of billions of gigabytes of health information are now being collected in electronic medical records, and three-quarters (76%) of more than 700 healthcare executives recently surveyed by PricewaterhouseCoopers LLP agree that the secondary use of this information will be their organization's greatest asset over the next five years.

3 Oct 2009

TMS Health expands its Boca Raton Headquarters

TMS Health, the largest provider of outbound and inbound Teleservices to the U.S. Pharmaceutical Industry, is expanding its Boca Raton headquarters.

3 Oct 2009

Americans want to be better informed about developments in cutting-edge technologies

Nanotechnology and synthetic biology continue to develop as two of the most exciting areas of scientific discovery, but research has shown that the public is almost completely unaware of the science and its applications.

3 Oct 2009